These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
138 related items for PubMed ID: 3124728
21. Efficacy of levofloxacin in the treatment of experimental endocarditis caused by viridans group streptococci. Entenza JM, Caldelari I, Glauser MP, Moreillon P. J Antimicrob Chemother; 1999 Dec; 44(6):775-86. PubMed ID: 10590278 [Abstract] [Full Text] [Related]
22. Relatively penicillin-resistant Streptococcus sanguis endocarditis in an adolescent. Boenning DA, Nelson LP, Campos JM. Pediatr Infect Dis J; 1988 Mar; 7(3):205-7. PubMed ID: 3357720 [No Abstract] [Full Text] [Related]
23. Differential response to benzylpenicillin in vivo of tolerant and non-tolerant variants of Streptococcus sanguis II. Meeson J, McColm AA, Acred P, Greenwood D. J Antimicrob Chemother; 1990 Jan; 25(1):103-9. PubMed ID: 2318747 [Abstract] [Full Text] [Related]
24. Comparison of single doses of amoxicillin or of amoxicillin-gentamicin for the prevention of endocarditis caused by Streptococcus faecalis and by viridans streptococci. Francioli P, Moreillon P, Glauser MP. J Infect Dis; 1985 Jul; 152(1):83-9. PubMed ID: 3925031 [Abstract] [Full Text] [Related]
25. Successful trovafloxacin prophylaxis against experimental streptococcal aortic valve endocarditis. Katsarolis I, Pefanis A, Iliopoulos D, Siaperas P, Karayiannakos P, Giamarellou H. Antimicrob Agents Chemother; 2000 Sep; 44(9):2564-6. PubMed ID: 10952619 [Abstract] [Full Text] [Related]
26. Single-dose rifampin prophylaxis for experimental endocarditis induced by high bacterial inocula of viridans streptococci. Malinverni R, Bille J, Glauser MP. J Infect Dis; 1987 Jul; 156(1):151-7. PubMed ID: 3598216 [Abstract] [Full Text] [Related]
27. Linezolid in prophylaxis against experimental aortic valve endocarditis due to Streptococcus oralis or Enterococcus faecalis. Athanassopoulos G, Pefanis A, Sakka V, Iliopoulos D, Perrea D, Giamarellou H. Antimicrob Agents Chemother; 2006 Feb; 50(2):654-7. PubMed ID: 16436723 [Abstract] [Full Text] [Related]
28. Effect of penicillin resistance on presentation and outcome of nonenterococcal streptococcal infective endocarditis. Hsu RB, Lin FY. Cardiology; 2006 Feb; 105(4):234-9. PubMed ID: 16534200 [Abstract] [Full Text] [Related]
29. Chemotherapy of experimental streptococcal endocarditis. IV. Further observations on prophylaxis. Pelletier LL, Durack DT, Petersdorf RG. J Clin Invest; 1975 Aug; 56(2):319-30. PubMed ID: 1150874 [Abstract] [Full Text] [Related]
30. Successful moxifloxacin prophylaxis against experimental streptococcal aortic valve endocarditis. Sakka V, Galani L, Pefanis A, Iliopoulos D, Athanasopoulos G, Donta I, Giamarellou H. J Antimicrob Chemother; 2005 Dec; 56(6):1160-2. PubMed ID: 16204339 [Abstract] [Full Text] [Related]
31. Treatment with various antibiotics of experimental endocarditis caused by penicillin-resistant Streptococcus sanguis. Martínez F, Martín-Luengo F, García A, Valdés M. Eur Heart J; 1995 May; 16(5):687-91. PubMed ID: 7588902 [Abstract] [Full Text] [Related]
33. Failure of erythromycin in preventing bacterial endocarditis. Eng RH, Wolff M, Smith SM. Arch Intern Med; 1982 Oct; 142(10):1958-9. PubMed ID: 7125782 [Abstract] [Full Text] [Related]